For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240823:nRSW6160Ba&default-theme=true
RNS Number : 6160B MyCelx Technologies Corporation 23 August 2024
23 August 2024
MYCELX Technologies Corporation
("MYCELX" or the "Company") (AIM:MYX)
Director Dealings & Total Voting Rights
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water
and clean air technology company established to transform the environmental
impact of industry, announces, further to the Placing and Subscription this
morning, the following participation by Directors of the Company.
Director Shares held prior to Admission New Shares Purchased Shares held post Admission Percentage of Enlarged Issued Share Capital
Thomas Lamb 325,175 48,836 374,011 1.54%
Connie Mixon(1) 2,803,944 100,632 2,931,576 12.06%
Andre Schnabl 118,011 48,836 166,847 0.69%
(1) Mrs. Mixon's shareholding includes 229,008 shares in the Company held by
her spouse.
Total Voting Rights
In conformity with the FCA's Disclosure Guidance and Transparency Rules (the
"Rules") provision 5.6.1, the Company would like to notify the market that
following Admission on 4 September 2024 its issued share capital will consist
of 24,315,271 Common Shares of US$0.025 each.
Shareholders should use 24,315,271 as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, the Company under the Rules.
Terms and definitions used in this announcement shall have the same meaning as
ascribed to them in the Proposed Placing and Subscription Announcement
released at 7:00 a.m. on 23 August 2024, unless the context requires
otherwise.
For further information please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity Limited (Nominated Adviser and Sole Broker)
Henry Fitzgerald-O'Connor Tel: +44 20 7523 8000
Charlie Hammond
Celicourt Communications (Financial PR)
Mark Antelme Tel: +44 20 7770 6424
Jimmy Lea
Charlie Denley-Myerson
Notifications of transactions of persons discharging managerial responsibility
or connected persons
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1. Thomas Lamb
2. Connie Mixon
3. Andre Schnabl
2 Reason for the notification
a) Position/status 1. Non-Executive Chairman
2. Chief Executive Officer
3. Non-Executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Mycelx Technologies Corporation
b) LEI 213800UJZINIK2VD1G48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Common shares of US$0.025
Identification code US62847T2024
b) Nature of the transaction Purchase of Common Shares
c) Price(s) and volume(s) Price(s) Volume(s)
1. 51.5 pence 1. 48,836
2. 51.5 pence 2. 100,632
3. 51.5 pence 3. 48,836
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 23 August 2024
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
N/A
N/A
e)
Date of the transaction
23 August 2024
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGZGZRGFZGDZM